Table 4 Comparison between pre-treatment and post-treatment lipid profile and Lp-PLA2 in patients who failed to achieve SVR (n = 4)
Lipid parameter | Time | Paired t-test | ||
|---|---|---|---|---|
Pre-treatment | 12 weeks post-treatment | t | p | |
LDL (mg/dl) | 33.75 ± 4.573 (27–37) | 36.5 ± 4.655 (30–41) | −2.200 | 0.115 |
Total cholesterol (mg/dl) | 114 ± 32.527 (87–158) | 117.5 ± 28.361 (88–153) | −1.000 | 0.391 |
HDL (mg/dl) | 38.75 ± 6.702 (32–48) | 37.25 ± 5.123 (30–42) | 0.878 | 0.444 |
Lp-PLA2 (ng/ml) | 370 ± 98.668 (260–474) | 392.25 ± 88.733 (319–500) | −1.648 | 0.198 |